StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SOURCENTRL.BO$107.50+3.00%
Fair $107.50+0.0%

SOURCENTRL.BO

Source Natural Foods and Herbal Supplements Limited

Consumer Defensive / Packaged FoodsBSE

$107.50

+3.30 (+3.00%)

Fairly Valued+0.0%Fair Value $107.50Fund rank 27/100 · Data gapFallback financials|
SA 46/C
F-Score: 5/9
Margin Compression

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $25.1M · quality 46.0/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 21/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Operating margin has declined for 3 consecutive years
Thesis & Journal · SOURCENTRL.BOLocal privado en este navegador · Source Natural Foods and Herbal Supplements Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$692M

P/E

24.9x

↑

EV/EBITDA

13.5x

↑

ROE

13.0%

↑

Gross Margin

25.5%

↓

Debt/Equity

0.33

↓
52-Week Range$108
$97$192

TradingView lightweight chart

SOURCENTRL.BO price, volumen y niveles de valoración

Último $113.30Periodo +2475.0%
Fair value: $107.50

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+27.8%

FCF CAGR

—

FCF margin

-0.1%

FCF / Net income

-0.01x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $449.2M · net income $29.0M · FCF $-240000.0

2022-FY → 2025-FY

Gross margin

25.5%-30.7% pts

Operating margin

9.2%-6.8% pts

Net margin

6.5%-4.8% pts

FCF margin

-0.1%+10.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$449.2M$449.2M$273.0M$197.7M$215.2M
Net Income$29.0M$29.0M$17.4M$21.2M$24.3M
EBITDA$51.2M$51.2M$44.2M$35.9M$43.2M
EPS4.514.512.703.303.78
Gross Margin25.5%25.5%38.5%50.2%56.2%
Operating Margin9.2%9.2%12.6%15.1%16.0%
Net Margin6.5%6.5%6.4%10.7%11.3%
Balance Sheet
Debt/Equity0.330.330.060.000.00
Current Ratio2.182.18———
Cash Flow
Free Cash Flow$-240000.00$-240000.00$26.9M$25.1M$-22.5M
Returns
ROE13.0%13.0%8.9%12.0%15.6%
Valuation
P/E24.8824.8833.6728.0526.96
EV/EBITDA13.5513.5511.9315.7815.00
P/B3.103.103.013.364.20
Growth & Yield
Revenue Growth64.6%64.6%38.1%-8.1%—
EPS Growth67.0%67.0%-18.2%-12.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

28.4%

muy exigente

EPS terminal req.

$9.54

Spread vs growth

38.7%

5Y implied EPS CAGR

20.7%

exigente

EPS terminal req.

$11.54

Spread vs growth

46.4%

10Y implied EPS CAGR

15.2%

exigente

EPS terminal req.

$18.59

Spread vs growth

51.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -31.4%

Total return

-31.4%

Start / end P/E

61.1x → 25.1x

EPS bridge

2.70 → 4.51

Residual

-39.5%

EPS growth+67.0%
Multiple rerating-58.9%
Dividend+0.0%
Residual / FX / buybacks / cross-term-39.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.